Debra Eiselt1. 1. Debra Eiselt, BSN, RN, Employee Health Coordinator, Infection Prevention & Control, Lakeview Hospital, Stillwater, MN, USA.
Abstract
BACKGROUND: Postoperative surgical site infections (SSIs) are a common complication of joint surgery. Prevention depends on adequate preoperative skin antisepsis. In previous studies, use of a 2% chlorhexidine gluconate (CHG) no-rinse cloth reduced SSI rates in general surgery patients. METHODS: Patients admitted for a total joint procedure used a skin antisepsis protocol incorporating 2% CHG no-rinse cloths to do a site-specific wash on the night before surgery and in the holding area just before surgery. RESULTS: In the 3 quarters before implementation of the protocol, the SSI rate was 3.19%. In the 3 quarters after the 2% CHG cloth was introduced, the SSI rate decreased to 1.59%, representing a 50.16% reduction in SSIs. CONCLUSIONS: The rate of SSI was cut in half after the introduction of 2% CHG no-rinse cloths in the place of a povidone-iodine (Betadine) skin antiseptic in orthopaedic patients undergoing total joint procedures. Further testing using randomization comparative protocols are required to conclude that the decreased SSI was in fact a direct result of the 2% CHG protocol.
BACKGROUND: Postoperative surgical site infections (SSIs) are a common complication of joint surgery. Prevention depends on adequate preoperative skin antisepsis. In previous studies, use of a 2% chlorhexidine gluconate (CHG) no-rinse cloth reduced SSI rates in general surgery patients. METHODS:Patients admitted for a total joint procedure used a skin antisepsis protocol incorporating 2% CHG no-rinse cloths to do a site-specific wash on the night before surgery and in the holding area just before surgery. RESULTS: In the 3 quarters before implementation of the protocol, the SSI rate was 3.19%. In the 3 quarters after the 2% CHG cloth was introduced, the SSI rate decreased to 1.59%, representing a 50.16% reduction in SSIs. CONCLUSIONS: The rate of SSI was cut in half after the introduction of 2% CHG no-rinse cloths in the place of a povidone-iodine (Betadine) skin antiseptic in orthopaedic patients undergoing total joint procedures. Further testing using randomization comparative protocols are required to conclude that the decreased SSI was in fact a direct result of the 2% CHG protocol.
Authors: Aaron J Johnson; Siraj A Sayeed; Qais Naziri; Harpal S Khanuja; Michael A Mont Journal: Clin Orthop Relat Res Date: 2012-01 Impact factor: 4.176
Authors: Deverick J Anderson; Kelly Podgorny; Sandra I Berríos-Torres; Dale W Bratzler; E Patchen Dellinger; Linda Greene; Ann-Christine Nyquist; Lisa Saiman; Deborah S Yokoe; Lisa L Maragakis; Keith S Kaye Journal: Infect Control Hosp Epidemiol Date: 2014-06 Impact factor: 3.254
Authors: Michael G Zywiel; Jacqueline A Daley; Ronald E Delanois; Qais Naziri; Aaron J Johnson; Michael A Mont Journal: Int Orthop Date: 2010-06-20 Impact factor: 3.075
Authors: Nicholas J Farber; Antonia F Chen; Sarah M Bartsch; Jody L Feigel; Brian A Klatt Journal: Clin Orthop Relat Res Date: 2013-10 Impact factor: 4.176